- 全部删除
您的购物车当前为空
CWI1-2 是一种有效的 IGF2BP2 抑制剂,通过结合 IGF2BP2 抑制其与 m6A 修饰的靶转录物的相互作用。CWI1-2 具有抗白血病活性,可诱导细胞凋亡 (apoptosis)和分化。

CWI1-2 是一种有效的 IGF2BP2 抑制剂,通过结合 IGF2BP2 抑制其与 m6A 修饰的靶转录物的相互作用。CWI1-2 具有抗白血病活性,可诱导细胞凋亡 (apoptosis)和分化。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 488 | In stock | |
| 5 mg | ¥ 1,070 | In stock | |
| 10 mg | ¥ 1,820 | In stock | |
| 25 mg | ¥ 2,970 | In stock | |
| 50 mg | ¥ 4,350 | In stock | |
| 100 mg | ¥ 6,150 | In stock | |
| 200 mg | ¥ 8,290 | In stock |
CWI1-2 相关产品
| 产品描述 | CWI1-2 is a potent IGF2BP2 inhibitor that inhibits its interaction with M6A-modified target transcripts by binding IGF2BP2. CWI1-2 has anti-leukemic activity and can induce apoptosis and differentiation. |
| 体外活性 | CWI1-2在0-1 μM的浓度范围内,对白血病展现出优异的抗癌效果,持续时间为24小时[1]。 |
| 体内活性 | 通过静脉注射,CWI1-2以5 mg/kg的剂量每日一次,连续给药7-10天,显著延迟了BMT(骨髓移植)受体B6.SJL(CD45.1)小鼠白血病的发病时间,并延长了生存时间,同时对体重无明显影响[1]。 |
| 分子量 | 519.77 |
| 分子式 | C22H17Cl3N6O3 |
| CAS No. | 2408590-36-1 |
| Smiles | ClC1=CC=C(O)C(C=NN=C(NN=CC2=CC(Cl)=CC=C2O)NN=CC3=CC(Cl)=CC=C3O)=C1 |
| 密度 | no data available |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 90 mg/mL (173.15 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.85 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容